IQVIA Holdings (IQV) recently forged a strategic partnership with Kexing Biopharm, aiming to bolster the clinical development and market integration of innovative therapeutics globally. Over the last ...

A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...

The agreement is for Kashiv BioSciences’ biosimilar candidate to Genentech and Novartis AG’s Xolair (omalizumab) in the ...

IQVIA Holdings stock surged on Tuesday after the clinical research and analytics company's second-quarter results topped ...

IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, finds itself at a ...

Review quarterly and annual revenue, net income, and cash flow for IQVIA Holdings Inc (IQV:XNYS) stock through the last fiscal year.

Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results , with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue guidance of $16.2 billion at the ...

IQVIA has seen an increase of 58.97% in its revenues since 2017. In addition, its net profit margin has strengthened since 2018. The CRO market expects to grow at a 7.42% CAGR between 2024 and ...

He joined IQVIA in 2003 and has been rising up the ranks ever since, from director of stats to leading a team over more than 50 to incorporate artificial intelligence into the company’s suite of ...